Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 108151-108200 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT03695315
Tissue-specific Insulin Resistance in Obstructive Sleep Apnea: Role of Hypoxia
N/AActive, not recruiting
60 participants
Started: Oct 31, 2018 · Completed: Dec 31, 2025
3 conditions2 sponsors1 location
NCT05203770
Adaptations of the Brain in Chronic Pain With Opioid Exposure I
N/AActive, not recruiting
250 participants
Started: Oct 31, 2018 · Completed: Jun 30, 2024
2 conditions3 sponsors2 locations
NCT04294199
Effect of Early Range of Motion Following First Time Patellar Dislocation
NAActive, not recruiting
60 participants
Started: Oct 31, 2018 · Completed: Aug 11, 2026
1 condition1 sponsor1 location
NCT03732820
Study on Olaparib Plus Abiraterone as First-line Therapy in Men With Metastatic Castration-resistant Prostate Cancer
PHASE3Active, not recruiting
895 participants
Started: Oct 31, 2018 · Completed: Apr 27, 2026
1 condition2 sponsors132 locations
NCT03698721
Urothelium Tissue Engineering Using Biopsies From Transurethral Resection of Prostate
N/ANot yet recruiting
365 participants
Started: Oct 31, 2018 · Completed: Oct 31, 2026
5 conditions1 sponsor0 locations
NCT03684863
Capecitabine in HER-2 Positive Breast Cancer With Pathologic Residual Tumors After Preoperative Chemotherapy
PHASE2Not yet recruiting
200 participants
Started: Oct 31, 2018 · Completed: Dec 31, 2025
1 condition1 sponsor0 locations
NCT03317405
Phase I Trial of Endoxifen Gel Versus Placebo in Women Undergoing Breast Surgery
PHASE1Active, not recruiting
32 participants
Started: Oct 31, 2018 · Completed: Aug 12, 2026
13 conditions1 sponsor3 locations
NCT03681210
Destination Therapy Post Approval Study
N/AActive, not recruiting
300 participants
Started: Oct 31, 2018 · Completed: Apr 30, 2026
1 condition1 sponsor47 locations
NCT03661307
Quizartinib, Decitabine, and Venetoclax in Treating Participants With Untreated or Relapsed Acute Myeloid Leukemia or High Risk Myelodysplastic Syndrome
PHASE1/PHASE2Recruiting
73 participants
Started: Oct 31, 2018 · Completed: Jan 1, 2026
5 conditions3 sponsors1 location
NCT03689595
Predicting Progression of Developing Myeloma in a High-Risk Screened Population (PROMISE)
N/ARecruiting
30,000 participants
Started: Oct 31, 2018 · Completed: Oct 31, 2033
1 condition1 sponsor1 location
NCT03672773
Talazoparib and Low-Dose Temozolomide in Treating Participants With Relapsed or Refractory Extensive-Stage Small Cell Lung Cancer
PHASE2Active, not recruiting
35 participants
Started: Oct 31, 2018 · Completed: Oct 1, 2026
2 conditions3 sponsors6 locations
NCT03705234
A Randomized Trial Assessing the Effects of Inclisiran on Clinical Outcomes Among People With Cardiovascular Disease
PHASE3Active, not recruiting
16,124 participants
Started: Oct 30, 2018 · Completed: Dec 31, 2049
1 condition3 sponsors2 locations
NCT03814252
Prospective Clinical Safety and Efficacy Study of Lesion-targeted MRI-TULSA for Localized Prostate Cancer
NAActive, not recruiting
62 participants
Started: Oct 30, 2018 · Completed: Dec 31, 2028
1 condition1 sponsor1 location
NCT04794777
"Comparing Salvage Radiotherapy and Individualized PSMA PET/CT Targeted Treatment in With Relapsing Prostate Cancer"
PHASE3Recruiting
450 participants
Started: Oct 30, 2018 · Completed: Oct 30, 2027
1 condition1 sponsor5 locations
NCT03635424
Medtronic Transcatheter Aortic Valve Replacement (TAVR) Low Risk Bicuspid Study
NAActive, not recruiting
150 participants
Started: Oct 30, 2018 · Completed: Dec 31, 2030
1 condition1 sponsor25 locations
NCT03707743
Registry of Patients With Acute/Subacute Type B Aortic Dissection Treated by Means of the STABILISE Technique (STABILISE)
N/AActive, not recruiting
200 participants
Started: Oct 30, 2018 · Completed: Dec 30, 2025
1 condition1 sponsor34 locations
NCT03827694
Non-Invasive Diagnosis of Pediatric Pulmonary Invasive Mold Infections
N/ARecruiting
400 participants
Started: Oct 30, 2018 · Completed: Dec 31, 2026
2 conditions3 sponsors33 locations
NCT03235245
Immunotherapy With Ipilimumab and Nivolumab Preceded or Not by a Targeted Therapy With Encorafenib and Binimetinib
PHASE2Active, not recruiting
271 participants
Started: Oct 30, 2018 · Completed: Jan 31, 2027
2 conditions1 sponsor38 locations
NCT03736538
Nitrous Oxide- Suicidal Ideation
PHASE1Enrolling by invitation
50 participants
Started: Oct 30, 2018 · Completed: Dec 31, 2025
4 conditions2 sponsors1 location
NCT07136324
Safety and Efficacy of EUS-RFA in the Treatment of Pancreatic Lesions: A Prospective Registry
N/AActive, not recruiting
100 participants
Started: Oct 30, 2018 · Completed: Jul 1, 2028
1 condition1 sponsor1 location
NCT06381271
Transcatheter Aortic Valve Replacement for Pure Severe Aortic Valve Regurgitation
N/ARecruiting
500 participants
Started: Oct 30, 2018 · Completed: Oct 31, 2034
1 condition1 sponsor1 location
NCT03203330
A Study to Determine the Safety and Efficacy of TG-C in Subjects with Kellgren and Lawrence Grade 2 or 3 OA of the Knee
PHASE3Active, not recruiting
535 participants
Started: Oct 30, 2018 · Completed: Jul 10, 2026
1 condition1 sponsor46 locations
NCT03653052
Do Changes in ctDNA Predict Response for Patients With Oesophageal Cancer Receiving Durvalumab
PHASE2Active, not recruiting
18 participants
Started: Oct 30, 2018 · Completed: Jun 30, 2026
1 condition2 sponsors1 location
NCT04331392
Online Memory Intervention for Individuals with Traumatic Brain Injury
NARecruiting
84 participants
Started: Oct 30, 2018 · Completed: Feb 28, 2027
4 conditions3 sponsors1 location
NCT04050644
Comparison of Treatment With Preservative-free Dexamethasone 0.1% (Monofree Dexamethason) and Diclofenac 0.1% (Dicloabak) Eye Drops Versus Preserved Dexamethasone 0.1% (Maxidex) and Diclofenac 0.1% (Voltaren Ophtha) Eye Drops After Cataract Surgery
PHASE4Recruiting
100 participants
Started: Oct 30, 2018 · Completed: Dec 31, 2024
1 condition2 sponsors2 locations
NCT03858231
Opioids Versus Non-Opioids Postoperative After Knee Arthroscopic Surgery
PHASE4Recruiting
148 participants
Started: Oct 29, 2018 · Completed: Jan 31, 2026
3 conditions1 sponsor1 location
NCT03794362
Measuring Analgesic Interventions
N/ARecruiting
120 participants
Started: Oct 29, 2018 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT03904173
Establishment of Molecular Profiling for Individual Clinical Routine Treatment Decision in Early Breast Cancer
N/AActive, not recruiting
2,300 participants
Started: Oct 29, 2018 · Completed: Dec 31, 2043
3 conditions3 sponsors5 locations
NCT03741127
Long-Term Follow-Up Study for Subjects Treated With P-BCMA-101
PHASE1Active, not recruiting
100 participants
Started: Oct 29, 2018 · Completed: Nov 30, 2032
1 condition2 sponsors13 locations
NCT03629171
Liposome-encapsulated Daunorubicin-Cytarabine and Venetoclax in Treating Participants With Relapsed, Refractory or Untreated Acute Myeloid Leukemia
PHASE2Recruiting
52 participants
Started: Oct 29, 2018 · Completed: Dec 31, 2026
2 conditions1 sponsor1 location
NCT03596645
A Study to Assess the Efficacy and Safety of Golimumab in Pediatric Participants With Moderately to Severely Active Ulcerative Colitis
PHASE3Active, not recruiting
84 participants
Started: Oct 29, 2018 · Completed: Feb 20, 2027
1 condition1 sponsor58 locations
NCT03569956
Shaving Satisfaction in Males With Skin Irritation From Shaving
NAActive, not recruiting
40 participants
Started: Oct 29, 2018 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT03744819
Biomarkers for Prediction of Tumor Response to Radiotherapy
N/ARecruiting
100 participants
Started: Oct 29, 2018 · Completed: Nov 30, 2026
1 condition2 sponsors1 location
NCT03575013
A Combination of Avelumab and Taxane (AVETAX) for Urothelial Cancer
PHASE1Active, not recruiting
21 participants
Started: Oct 29, 2018 · Completed: Feb 23, 2026
1 condition3 sponsors1 location
NCT03322267
Adjuvant Pembrolizumab for Patients With Locally Advanced Esophageal Squamous Cell Carcinoma at High Risk of Recurrence
PHASE2Active, not recruiting
26 participants
Started: Oct 27, 2018 · Completed: Dec 30, 2025
1 condition2 sponsors1 location
NCT05918666
National Register of Actionable Mutations
N/ARecruiting
3,000 participants
Started: Oct 27, 2018 · Completed: Oct 27, 2026
1 condition12 sponsors42 locations
NCT03375320
Testing Cabozantinib in Patients With Advanced Pancreatic Neuroendocrine and Carcinoid Tumors
PHASE3Active, not recruiting
298 participants
Started: Oct 26, 2018 · Completed: Aug 19, 2026
28 conditions1 sponsor436 locations
NCT03455504
Venetoclax Add in Combination With Fludarabine, Cyratabine and Idarubicine in Induction for Acute Myelid Leukemia
PHASE2Active, not recruiting
124 participants
Started: Oct 26, 2018 · Completed: Jan 31, 2025
1 condition1 sponsor22 locations
NCT03631420
Mesenchymal Stem Cells for Prevention of Bronchopulmonary Dysplasia in Infants
PHASE1Recruiting
9 participants
Started: Oct 26, 2018 · Completed: Jul 31, 2027
1 condition1 sponsor1 location
NCT03664869
Electromotive Mitomycin-C (EMDA-MMC) in Preventing Recurrences in High-risk Non-muscle-invasive Bladder Cancer
PHASE3Recruiting
300 participants
Started: Oct 26, 2018 · Completed: Nov 1, 2025
1 condition2 sponsors7 locations
NCT03601455
Radiation Therapy and Durvalumab With or Without Tremelimumab in Treating Participants With Unresectable, Locally Advanced, or Metastatic Bladder Cancer
PHASE2Active, not recruiting
13 participants
Started: Oct 26, 2018 · Completed: Jan 31, 2027
4 conditions2 sponsors1 location
NCT06204523
Prospective Validation of a DNA Damage Repair-Hippo Pathway Signature in Patients With Advanced Gastric Cancer
N/AActive, not recruiting
167 participants
Started: Oct 26, 2018 · Completed: Aug 30, 2024
2 conditions7 sponsors1 location
NCT03897270
Photoacoustic Imaging of the Breast in Patients With Breast Cancer and Healthy Subjects
NARecruiting
400 participants
Started: Oct 25, 2018 · Completed: Oct 25, 2025
2 conditions2 sponsors1 location
NCT03753490
ABC-Scores for Reduction of Stroke and Mortality in Atrial Fibrillation - The ABC-AF Study
NAActive, not recruiting
3,933 participants
Started: Oct 25, 2018 · Completed: May 31, 2028
1 condition5 sponsors1 location
NCT03721744
A Study of GB201 in Combination With Weekly Paclitaxel and Low-dose Gemcitabine in Patients With Pancreatic Cancer
PHASE2/PHASE3Recruiting
336 participants
Started: Oct 25, 2018 · Completed: Sep 30, 2025
1 condition1 sponsor38 locations
NCT03694145
Predicting Diabetic Retinopathy From Risk Factor Data and Digital Retinal Images
N/AActive, not recruiting
300 participants
Started: Oct 25, 2018 · Completed: Jul 31, 2025
2 conditions4 sponsors3 locations
NCT03943745
EEG Changes During Induction of Propofol Anesthesia
N/ARecruiting
50 participants
Started: Oct 25, 2018 · Completed: May 31, 2024
2 conditions3 sponsors1 location
NCT03564197
18F-PD-L1 PET/CT in Nivolumab Treated Patients With NSCLC
NARecruiting
80 participants
Started: Oct 25, 2018 · Completed: Dec 30, 2024
1 condition2 sponsors8 locations
NCT03740126
Surveillance With PET/CT and Liquid Biopsies of Stage I-III Lung Cancer Patients After Completion of Definitive Therapy
NAActive, not recruiting
750 participants
Started: Oct 25, 2018 · Completed: Aug 31, 2026
1 condition3 sponsors3 locations
NCT03586609
Venetoclax, Cladribine, Low Dose Cytarabine, and Azacitidine in Treating Patients With Previously Untreated Acute Myeloid Leukemia
PHASE2Recruiting
145 participants
Started: Oct 25, 2018 · Completed: Apr 30, 2027
1 condition1 sponsor1 location